• UroGen Pharma (NASDAQ:URGN) Given "Buy" Rating at D. Boral Capital

    Источник: Buzz FX / 15 янв 2025 11:46:17   America/New_York


    UroGen Pharma (NASDAQ:URGN) Given "Buy" Rating at D. Boral Capital Written by MarketBeat January 15, 2025 Share Link copied to clipboard. UroGen Pharma ( NASDAQ:URGN - Get Free Report ) 's stock had its "buy" rating reaffirmed by D.
    Read more...
Опубликовать